Skip to content
Peptilyze
CompoundsShopsCompareGuidesMethod
Neuro & cognitive

Cerebrolysin studies

719 journal papers mention Cerebrolysin in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.

Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether Cerebrolysin is safe, effective or approved for any use.

Compare Cerebrolysin prices, from €54.00 →

Papers
719
655 articles, 64 reviews
Earliest paper
1979
Most papers in 2025 (51)
Open access
49%
free to read somewhere
Reviews
9%
of all papers listed

What kind of studies

Of 629 papers in PubMed that mention Cerebrolysin in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.

  • Randomized controlled trials61
  • Other clinical trials28
  • Meta-analyses and systematic reviews30
  • Other reviews96
  • Case reports26
  • Animal studies only195
  • Studies in humans326

Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).

Registered clinical studies

Studies on ClinicalTrials.gov that mention Cerebrolysin in their intervention details. A registration says a study is planned or running, not what it found.

Registered
43
Completed
19
Ongoing or planned
9
Phase 1
3
Phase 2
11
Phase 3
7
  1. Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic Stroke

    NCT07846488Not yet recruitingstarted 2026-12-01

  2. Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy

    NCT06339411Not yet recruitingPhase 2started 2026-09-01

  3. Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness

    NCT04427241RecruitingPhase 4started 2023-06-01

  4. Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU

    NCT06052787CompletedPhase 3started 2023-09-01

  5. Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

    NCT05821075RecruitingPhase 1 / Phase 2started 2023-08-24

The five most recently updated studies. See all 43 on ClinicalTrials.gov. Source: ClinicalTrials.gov (U.S. National Library of Medicine). Studies are found by the compound's name, so a few may be about something else.

Papers per year

1997 to 2026, peak 51 papers in a year. The latest year may still be incomplete.

1997: 6 papers1998: 6 papers1999: 9 papers2000: 18 papers2001: 9 papers2002: 6 papers2003: 7 papers2004: 9 papers2005: 8 papers2006: 15 papers2007: 7 papers2008: 12 papers2009: 17 papers2010: 16 papers2011: 27 papers2012: 15 papers2013: 22 papers2014: 25 papers2015: 26 papers2016: 33 papers2017: 42 papers2018: 30 papers2019: 46 papers2020: 36 papers2021: 43 papers2022: 30 papers2023: 46 papers2024: 47 papers2025: 51 papers2026: 33 papers19972026

Where it is published

  1. S S Korsakov Journal of Neurology and Psychiatry50 papers
  2. Alzheimer s & Dementia33 papers
  3. Journal of Medicine and Life20 papers
  4. European Neuropsychopharmacology15 papers
  5. Neuroscience and Behavioral Physiology14 papers

The papers

ShowAllOpen accessReviews

Most citedName in the title

  1. Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke

    Chunling Zhang, Michael Chopp, Yisheng Cui et al. · Journal of Neuroscience Research · 2010

    Animal studyOpen access194 citationsRead the open copy →

  2. Cerebrolysin and Recovery After Stroke (CARS)

    Dafin Fior Muresanu, Wolf‐Dieter Heiss, Volker Hoemberg et al. · Stroke · 2015

    Randomized trial · Phase 2Open access · CC BY-NC-ND160 citationsRead the open copy →

  3. Sonic Hedgehog Signaling Pathway Mediates Cerebrolysin-Improved Neurological Function After Stroke

    Li Zhang, Michael Chopp, Dieter H. Meier et al. · Stroke · 2013

    Animal study147 citations

  4. Cerebrolysin in Patients With Acute Ischemic Stroke in Asia

    Wolf‐Dieter Heiss, Michael Brainin, Natan M. Bornstein et al. · Stroke · 2012

    Randomized trial · Phase 4128 citations

  5. Neuroprotective treatment with Cerebrolysin in patients with acute stroke: a randomised controlled trial

    G. Ladurner, Pavel Kalvach, Herbert Moessler · Journal of Neural Transmission · 2004

    Randomized trial116 citations

  6. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials

    Natan M. Bornstein, Alla B. Guekht, Johannes Vester et al. · Neurological Sciences · 2017

    Meta-analysisOpen access · CC BY114 citationsRead the open copy →

  7. Efficacy of the Peptidergic Nootropic Drug Cerebrolysin in Patients with Senile Dementia of the Alzheimer Type (SDAT)

    Eckart Rüther, R. Ritter, M. Apecechea et al. · Pharmacopsychiatry · 1994

    Randomized trial106 citations

  8. A Prospective, Randomized, Placebo-Controlled, Double-Blind Trial about Safety and Efficacy of Combined Treatment with Alteplase (rt-PA) and Cerebrolysin in Acute Ischaemic Hemispheric Stroke

    Wilfried Lang, Christian H. Stadler, Zdravka Poljaković et al. · International Journal of Stroke · 2012

    Randomized trial104 citations

  9. Effects of Cerebrolysin™ on neurogenesis in an APP transgenic model of Alzheimer’s disease

    Edward M. Rockenstein, Michael Mante, Anthony Adame et al. · Acta Neuropathologica · 2006

    Animal study99 citations

  10. A 24‐week, double‐blind, placebo‐controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

    X. Anton Alvarez, R Cacabelos, Marta Laredo et al. · European Journal of Neurology · 2006

    Randomized trial98 citations

  11. Cerebrolysin, a Mixture of Neurotrophic Factors Induces Marked Neuroprotection in Spinal Cord Injury Following Intoxication of Engineered Nanoparticles from Metals

    Preeti Kumaran Menon, Dafin Fior Muresanu, Aruna Sharma et al. · CNS & Neurological Disorders - Drug Targets · 2012

    Review97 citations

  12. Cerebrolysin for vascular dementia

    Ning Chen, Mi Yang, Jian Guo et al. · Cochrane Database of Systematic Reviews · 2013

    Meta-analysisOpen access93 citationsRead the open copy →

  13. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study

    Chun‐Chung Chen, Sung-Tai Wei, Shiu-Chiu Tsaia et al. · British Journal of Neurosurgery · 2013

    Randomized trial · Phase 292 citations

  14. Cerebrolysin reduces blood‐cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat

    Hari Shanker Sharma, Sibilla Zimmermann‐Meinzingen, Conrad E. Johanson · Annals of the New York Academy of Sciences · 2010

    Animal study91 citations

  15. Cerebrolysin decreases amyloid‐β production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease

    Edward M. Rockenstein, Magdalena Torrance, Michael Mante et al. · Journal of Neuroscience Research · 2006

    Animal study88 citations

  16. Antiapoptotic effects of the peptidergic drug Cerebrolysin on primary cultures of embryonic chick cortical neurons

    M. Hartbauer, Birgit Hutter‐Paier, Gerhard Skofitsch et al. · Journal of Neural Transmission · 2001

    Animal study84 citations

  17. The neuroprotective effects of Cerebrolysin? in a transgenic model of Alzheimer?s disease are associated with improved behavioral performance

    Edward M. Rockenstein, Anthony Adame, Michael Mante et al. · Journal of Neural Transmission · 2003

    Animal study83 citations

  18. Cerebrolysin

    Greg L. Plosker, Serge G. Gauthier · Drugs & Aging · 2009

    Review82 citations

  19. Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke

    Won Hyuk Chang, Chang-Hyun Park, Deog Young Kim et al. · BMC Neurology · 2016

    Randomized trial · Phase 4Open access · CC BY78 citationsRead the open copy →

  20. Intranasal Cerebrolysin Attenuates Learning and Memory Impairments in D-galactose-Induced Senescence in Mice

    Ehsan Pourmemar, Alireza Majdi, Morteza Haramshahi et al. · Experimental Gerontology · 2016

    Animal study76 citations

  21. Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1α Pathway

    Xin Guan, Yunjie Wang, Guoyin Kai et al. · Frontiers in Pharmacology · 2019

    Open access · CC BY70 citationsRead the open copy →

  22. Efficacy and safety comparison of DL-3-n-butylphthalide and Cerebrolysin: Effects on neurological and behavioral outcomes in acute ischemic stroke

    Lixia Xue, Ting Zhang, Yuwu Zhao et al. · Experimental and Therapeutic Medicine · 2016

    Open access70 citationsRead the open copy →

  23. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double‐blind, controlled trial investigating three dosages of Cerebrolysin

    X. Anton Alvarez, Ramón Cacabelos, Carolina Sampedro et al. · European Journal of Neurology · 2010

    Randomized trial69 citations

  24. A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease

    Eckart Rüther, Rachel Husmann, E. Kinzler et al. · International Clinical Psychopharmacology · 2001

    Randomized trial68 citations

  25. Combination Treatment in Alzheimers Disease: Results of a Randomized, Controlled Trial with Cerebrolysin and Donepezil

    X. Anton Alvarez, Ramón Cacabelos, Carolina Sampedro et al. · Current Alzheimer Research · 2011

    Randomized trial · Phase 267 citations

  26. Cerebrolysin in Vascular Dementia: Improvement of Clinical Outcome in a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

    Alla B. Guekht, Herbert Moessler, Philipp H. Novak et al. · Journal of Stroke and Cerebrovascular Diseases · 2010

    Randomized trial67 citations

  27. Cerebrolysin for vascular dementia

    Shuhui Cui, Ning Chen, Mi Yang et al. · Cochrane Database of Systematic Reviews · 2019

    Review65 citations

  28. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease

    Kiren K. Ubhi, Edward M. Rockenstein, Rubén Antonio Vázquez‐Roque et al. · Journal of Neuroscience Research · 2012

    Study in humans65 citations

  29. Cerebrolysin Ameliorates Performance Deficits, and Neuronal Damage in Apolipoprotein E-Deficient Mice

    Eliezer Masliah, Franz Armasolo, Isaac Veinbergs et al. · Pharmacology Biochemistry and Behavior · 1999

    Animal study64 citations

  30. Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study

    Liliana Francis Turner, Věra Valoušková · Neuroscience Letters · 1996

    Animal study64 citations

  31. Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use

    Gavrilova Si, Antón Álvarez · Medicinal Research Reviews · 2020

    Review61 citations

  32. Cerebrolysin improves cognitive performance in rats after mild traumatic brain injury

    Yanlu Zhang, Michael Chopp, Yuling Meng et al. · Journal of neurosurgery · 2015

    Animal studyOpen access61 citationsRead the open copy →

  33. Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia

    Rubén Antonio Vázquez‐Roque, Brenda Ramos, Carolina Tecuatl et al. · Journal of Neuroscience Research · 2011

    Animal studyOpen access61 citationsRead the open copy →

  34. Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent

    Michel Panisset, Serge G. Gauthier, Herbert Moessler et al. · Journal of Neural Transmission · 2002

    Randomized trial61 citations

  35. A Double‐Blind, Placebo‐Controlled, Multicenter Study of Cerebrolysin for Alzheimer's Disease

    Chul‐Young Bae, Choo‐Yon Cho, Kyunghee Cho et al. · Journal of the American Geriatrics Society · 2000

    Randomized trialOpen access · CC BY-NC-ND61 citationsRead the open copy →

  36. Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer’s disease

    Z.-H. Wei, Qianfeng He, H. Wang et al. · Journal of Neural Transmission · 2007

    Meta-analysis59 citations

  37. Cerebrolysin enhances functional recovery following focal cerebral infarction in rats

    JingMei Ren, Dana K. Sietsma, Shumei Qiu et al. · Restorative Neurology and Neuroscience · 2007

    Animal study59 citations

  38. Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes

    Brian Fiani, Claudia Covarrubias, Amelia Wong et al. · Neurological Sciences · 2021

    Review58 citations

  39. Cerebrolysin in Mild-to-Moderate Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Clinical Trials

    Serge G. Gauthier, Jefferson V. Proaño, Jianping Jia et al. · Dementia and Geriatric Cognitive Disorders · 2015

    Meta-analysis57 citations

  40. Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial

    Dafin Fior Muresanu, Ioan Ştefan Florian, V. Hömberg et al. · Neurological Sciences · 2020

    Randomized trial56 citations

LatestName in title or abstract

  1. Expert Council resolution: adjunctive pharmacotherapy for hyperkinetic disorders (attention deficit hyperactivity disorder) in children and adolescents

    Oleg L. Lapochkin, Зыков Валерий Петрович, Nikolay N. Zavadenko et al. · S S Korsakov Journal of Neurology and Psychiatry · 2026

    Study in humans

  2. Prospects of Therapy for Post-Stroke Aphasia

    Anna Nicolaevna Bogolepova · Neuroscience and Behavioral Physiology · 2026

  3. The neuroprotective effect of resveratrol loaded lipid-core nanocapsules and cerebrolysin on midbrain of parkinsonism albino rats model: histological study

    Saad Hassouna, M D Safwat, Mohamed Ashmawy et al. · The Egyptian Journal of Histology · 2026

    Open access · CC BYRead the open copy →

  4. An Adaptive, Time-Informed, Phenotype-Guided Pharmacological Framework for Severe Traumatic Brain Injury : A Hypothesis-Driven Narrative Review

    Jae Min Choi, Kwang Wook Jo · Journal of Korean Neurosurgical Society · 2026

    ReviewOpen access · CC BY-NCRead the open copy →

  5. The Twenty-First Reported Patient with Complete Remission of the Core Autistic Features: A Child with a Previously Unrecognized Autism–Craniofacial Dysmorphism Syndrome

    Aamir Jalal Al-Mosawi · Brain and Neurological Disorders · 2026

    Open access · CC BYRead the open copy →

  6. A comparative clinical and economic advisability of neuroprotective therapy with ethylmethylhydroxypyridine succinate and Cerebrolysin in patients with ischaemic stroke

    Evgenia Kochetkova, A. A. Astapovskii, Vladimir N. Drozdov et al. · Neurology neuropsychiatry Psychosomatics · 2026

    Open access · CC BYRead the open copy →

  7. Post-endovascular thrombectomy perfusion imaging (CT and MR) as a prognostic biomarker and patient-selection tool for adjuvant therapy: A systematic review, meta-analysis, and clinical threshold framework

    Roni Eichel, Michael Teitcher, Stefan Mausbach et al. · Journal of Stroke and Cerebrovascular Diseases · 2026

    Meta-analysisOpen access · CC BYRead the open copy →

  8. Adjunctive Cerebrolysin therapy following mechanical thrombectomy for tandem right internal carotid artery and middle cerebral artery occlusion with residual post-procedural perfusion deficit: a case report

    Natan Meir Bornstein, Roni Eichel, Stefan Mausbach et al. · Journal of Medicine and Life · 2026

    Case reportOpen access · CC BYRead the open copy →

  9. Research-Evidence-Practice Gaps in Post-stroke Neuro-recovery Pharmacological Therapies in Asia

    Hou Chang Chiu, Yangchen Yangchen, Dayangku Siti Nur Ashikin Pengiran Tengah et al. · Cerebrovascular Diseases Extra · 2026

    Open access · CC BY-NCRead the open copy →

  10. Cognitive impairments in a comorbid patient: possibilities for correction

    Pavel Rudolfovich Kamchatnov, Ekaterina V. Mityaeva, D.T. Chipova et al. · The Clinician · 2026

    Open access · CC BYRead the open copy →

  11. ĐẶC ĐIỂM LÂM SÀNG, HÌNH ẢNH NÃO VÀ KẾT QUẢ ĐIỀU TRỊ HỖ TRỢ CỦA CEREBROLYSIN TRÊN BỆNH NHÂN NHỒI MÁU NÃO CẤP

    Tấn Hào Nguyễn, Hữu Phúc Ngô, Văn Minh Lê et al. · Tạp chí Y Dược học Cần Thơ · 2026

    Open access · CC BY-NC-SARead the open copy →

  12. Predictors of Psychoactive and Nootropic Substance Use Among Romanian University Healthcare Students: The Interplay Between Academic Anxiety and Educational Advancement

    Ioana-Cezara Caba, Magdalena Iorga, Iustina-Gabriela Mihăianu et al. · Healthcare · 2026

    Open access · CC BY1 citationsRead the open copy →

  13. The Effect of Cerebrolysin on the Development of Skills in Patients after Acute Cerebrovascular Accidents

    А. А. Шмонин, I.Kh. Kashaev, Е. А. Лучинин et al. · Neuroscience and Behavioral Physiology · 2026

  14. The Effect of Neuroprotectors on BDNF, Tumor Necrosis Factor Alpha, and Apoptosis Marker Levels in Acute Cerebrovascular Accidents

    A. V. Shchulkin, Ivan Vladimirovich Chernykh, Yu. V. Abalenikhina et al. · Neuroscience and Behavioral Physiology · 2026

  15. Improvement of aphasia deficits following traumatic intracranial hemorrhage: a case report

    Junhyun Choi · Journal of Medicine and Life · 2026

    Case reportOpen access · CC BYRead the open copy →

  16. Cerebrolysin in neurology and intensive care: new clinical trials and their implications for routine care

    Jacek Staszewski, Aleksander Dȩbiec, Bartosz Rustecki et al. · Lekarz Wojskowy · 2026

    Open access · CC BY-NC-SARead the open copy →

  17. IMMEDIATE AND LONG-TERM RESULTS OF THE USE OF NEUROPROTECTIVE DRUGS IN THE TREATMENT OF ISCHEMIC STROKE

    Бекбосынов Асхат Жунусович, Javli Sultanov · Ġylym men densaulyķ saķtau. · 2026

    Open access · CC BYRead the open copy →

  18. EFFECTIVENESS OF CEREBROLYSIN IN THE TREATMENT OF ENCEPHALOPATHY IN CHRONIC KIDNEY DISEASE

    Dilbar Rakhmatova · Central Asian Journal of Medicine · 2026

    Open accessRead the open copy →

  19. The Efficacy and Safety of Cerebrolysin on Functional Outcomes in Acute Ischemic Stroke: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials (P7-4.011)

    Rahman Syed, Ameer Afzal Khan, Anfal Khan et al. · Neurology · 2026

    Review

  20. Adjunctive Cerebrolysin therapy following mechanical thrombectomy for acute basilar artery occlusion: a case report

    Marina Roje Bedeković, Jerković Ivona, Marijana Bosnar Puretić · Journal of Medicine and Life · 2026

    Case reportOpen access · CC BYRead the open copy →

  21. Cerebrolysin as an adjunct to speech-language therapy in post-stroke Wernicke’s aphasia: a case report

    Marina Romano · Journal of Medicine and Life · 2026

    Case reportOpen access · CC BYRead the open copy →

  22. Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothelial Cell Permeability

    Hua Teng, Chao Li, Mingjin Wang et al. · Cells · 2026

    Study in humansOpen access · CC BYRead the open copy →

  23. Therapy prospects for post-stroke aphasia

    Anna Nicolaevna Bogolepova · S S Korsakov Journal of Neurology and Psychiatry · 2026

    Review

  24. Biochemical and Pharmacological Studies on Kynurenic Acid Metabolism in the Helix pomatia—Snail Model of Learning and Memory

    Halina Baran, Carina Kronsteiner · Biomolecules · 2026

    Animal studyOpen access · CC BYRead the open copy →

  25. The effect of neuroprotectors on the level of BDNF, tumor necrosis factor alpha and apoptosis markers, and in acute cerebrovascular accidents

    A. V. Shchulkin, Ivan Vladimirovich Chernykh, Yu. V. Abalenikhina et al. · S S Korsakov Journal of Neurology and Psychiatry · 2026

    Animal study

  26. The effect of Cerebrolysin on the development of skills in patients after acute cerebrovascular accidents

    А. А. Шмонин, I.Kh. Kashaev, Е. А. Лучинин et al. · S S Korsakov Journal of Neurology and Psychiatry · 2026

    Meta-analysis

  27. Efficacy and Safety of Cerebrolysin as an Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis of Observational Studies

    Abdullah Afridi, Fatima Sajjad, Ayesha Arshad et al. · Brain and Behavior · 2026

    Meta-analysisOpen access · CC BY2 citationsRead the open copy →

  28. Neuronutraceuticals for Alzheimer's Disease Treatment: A Systematic Review of Randomised Controlled Trials Over the Last 20 Years

    Mehmet Akif Topçuoğlu, Esen Saka · Phytochemicals in Food and Medicine · 2026

    ReviewOpen access · CC BYRead the open copy →

  29. Cerebrolysin after Endovascular Thrombectomy in Stroke: 12‑Month Functional Outcomes in a Propensity‑Matched Cohort

    Jacek Staszewski, Aleksander Dȩbiec, Katarzyna Agnieszka Gniadek-Olejniczak et al. · Translational Stroke Research · 2026

    Study in humansOpen access · CC BY-NC-NDRead the open copy →

  30. Experience of using of Cerebrolysin in comprehensive rehabilitation of a patient after ischemic stroke with motor deficit and aphasia

    Svetlana E. Khatkova, O S Pavlyuchenkova, A V Golovanova et al. · S S Korsakov Journal of Neurology and Psychiatry · 2026

    Case report

  31. Cerebrolysin, hemorrhagic transformation, and anticoagulation timing after reperfusion therapy in stroke: post hoc secondary analysis of the CEREHETIS trial

    Калинин Михаил Николаевич, Dina Rustemovna Khasanova · Frontiers in Pharmacology · 2026

    Open access · CC BY2 citationsRead the open copy →

  32. Cerebrolysin and Risk of Hemorrhagic Transformation: A Pooled Analysis of Recent Studies

    Bassel Alrabadi, Yousef Alghzawi, Natalie Bandak · Journal of Clinical Neurology · 2026

    Open access · CC BY-NCRead the open copy →

  33. Very Early Short‐Course Cerebrolysin After Tenecteplase and Mechanical Thrombectomy: A Case Report

    Hanna Ziąbska, Adam Kobayashi, Michal Adam Karlinski · Case Reports in Neurological Medicine · 2026

    Open access · CC BYRead the open copy →

  34. Use of nootropics in Alzheimer’s disease: An analysis of regulatory positions and drug policies in the countries of the Commonwealth of Independent States

    Elvira Grigorievna Alexandrova, Tatyana Rudolfovna Abakumova, Лилия Евгеньевна Зиганшина · International Journal of Risk & Safety in Medicine · 2025

    Study in humans

  35. Cerebrolysin Ameliorates Age-Induced Dendritic Spine Degeneration and Memory Decline in C57BL6 Mice

    Leonardo Aguilar‐Hernández, Gabriel D. Flores‐Gómez, Juan Nácher et al. · Neurochemical Research · 2025

    Animal studyOpen access · CC BY2 citationsRead the open copy →

  36. Cerebroprotection in acute ischemic stroke: Perspectives on combining cerebrolysin with recanalization therapy

    Marc Ribó, Jacek Staszewski, Steven R. Zeiler et al. · Journal of Stroke and Cerebrovascular Diseases · 2025

    ReviewOpen access3 citationsRead the open copy →

  37. Combined citicoline and Cerebrolysin for neuroprotection in traumatic brain injury: a retrospective cohort analysis

    Philipp Schlager, Ivan Grgac, Guenther Herzer et al. · Frontiers in Neurology · 2025

    Open access · CC BY2 citationsRead the open copy →

  38. The First Documented Case of Joubert Syndrome in Iraq: A Novel Variant

    Aamir Jalal Al-Mosawi · Mathews Journal of Pediatrics · 2025

    Open access · CC BYRead the open copy →

  39. Neuroprotective Effects of Cerebrolysin in Moderate Traumatic Brain Injury with Nonoperative Lesions: A 6-Month Prospective Cohort Analysis

    Panu Boontoterm, Siraruj Sakoolnamarka, Karanarak Urasyanandana · Asian Journal of Neurosurgery · 2025

    Open access · CC BY-NC-NDRead the open copy →

  40. Autism and Focal Seizures Associated with Left Hemispheric Cortical Atrophy: A Novel Clinical Pattern

    Aamir Jalal Al-Mosawi · Mathews Journal of Psychiatry & Mental Health · 2025

    Open access · CC BYRead the open copy →

Each list shows up to 40 papers.See all 719 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:26 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.